Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Power Mall warning letter

This article was originally published in The Tan Sheet

Executive Summary

FDA cites claims that Power Mall's Q Gel dietary supplement can "provide effective treatment of heart disease, chronic fatigue and support during cancer treatment" in a recent warning letter to the company. A review of the firm's website also finds that Gastro Enzymes claims to treat "ulcers, colitis, duodenal ulcer, gastritis, unexplained blood in urine..." the agency adds. Other products cited in the letter for making drug claims include Taurine Spray, AsmaSpray,D-Lenolate,Curcumin98,OxySorb, Eskimo 3 Fish Oil and AtaXanthin. FDA allows Power Mall 15 working days to notify the agency of the steps it is taking to correct the violations...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel